Drug Delivery 2007 has been organized to provide a critical examination of the drug delivery industry as well as insight from key industry leaders concerning cutting edge drug delivery technology, structuring mutually beneficial deals and the drug delivery industry's impact on the field of biotechnology.
Minneapolis, MN (PRWeb) February 19, 2007 -- Drug Delivery 2007 has been organized to provide a critical examination of the drug delivery industry as well as insight from key industry leaders concerning cutting edge drug delivery technology, structuring mutually beneficial deals and the drug delivery industry's impact on the field of biotechnology.
This conference will also provide an integral forum for leaders of the drug delivery, biotech and pharmaceutical industries to share ideas, network with other delegates and advance understanding of new drug delivery technologies.
In addition, there will be a pre-conference workshop on Quantitative Deal Structure in Drug Delivery Partnerships. For more information about this workshop, visit www.arrowheadpublishers.com/conferences/drugdelivery2007/DrugDeliveryWorkshop.pdf
Key Themes
- A critical examination of key emerging technologies in injectable, inhalable, transdermal, ophthalmic, intranasal, nanotechnology and oral drug delivery
- Patent and IP valuation
- Formation of successful alliances
- Transitioning from drug delivery to specialty pharma
- Making the deal - structuring mutually beneficial licensing arrangements
- Unlocking the door to delivery of macromolecules Investing in drug delivery - insights into acquring capital and advancing business models
Speakers at this Event Include:
- Allen Downs, Sr. Exec Dir Licensing, Purdue Pharma
- Dr. Charles Hardy - Biomedical Scientist, Biovaluation & Analysis, Inc
- Dr. Igor Gonda - CEO, Aradigm
- Dr. Edward Maggio - CEO, Aegis Therapeutics
- Timothy Sullivan - CEO, Mystic Pharmaceuticals
- Dr. Lynnor Stevenson - CEO, Alta Biomedical
- Dr. Rajiv Khosla - VP Business Development Services - Biovail
- Lewis Bender - Sr VP Business Development - Emisphere Technologies
- Brian Gorin - Managing Principal - Analysis Group
- Mr. Steven Damon - VP Business Development - Altea Therapeutics
- Edward Tuttle - Managing Principal - Analysis Group
- Dr. Alain Rolland - Sr VP Product Development - Vical Incorporated
- Dr. Robert Lee, VP Pharmaceutical Development - Novavax
- Anil Dasu, VP Medical Device Engineering - Anesiva
- Samantha Miller, VP Business Development - Anesiva
For more infomation about this conference, please visit www.arrowheadpublishers.com/conferences/drugdelivery2007 or contact us at 612-929-5203 or sales-at-arrowheadpublishers.net
To enquire about sponsorship and/or exhibiting at this conference please contact marketing-at-arrowheadpublishers.com
###
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1TdW1tLUluc2UtSG9yci1NYWduLVplcm8=
|
